Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFCT-0502: Maintenance Gemcitabine or Erlotinib in NSCLC
NCT00300586Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Hospices Civils de Lyon. Started Jun 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00300586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300586.